ReviewFrontiers in public health2026
Social prescribing for refugee populations: a rapid realist review of international evidence.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Social prescribing offers potential for addressing social determinants of health and supporting health equity among disadvantaged groups. However, evidence for refugee populations remains limited, despite this group facing profound social and systemic barriers. This rapid realist review synthesizes social prescribing and comparable social-capital based intervention evidence to address this gap. Methods: We conducted a RAMESES-compliant rapid realist review supported by an expert advisory board. Searches across six databases (2014-2024) were supplemented by grey literature and citation chasing strategies. Eligible studies included refugee, asylum-seekers and forcibly displaced populations engaged in either formal social prescribing or comparably operationalized social-capital interventions. Synthesis developed Context-Mechanism-Outcome configurations organized into intervention families and articulated as If-Then programme theories. Results: From 7,436 records, 39 studies contributed to synthesis. As anticipated, formal social prescribing evidence was limited; findings are therefore substantially theory-informed extrapolations from social-capital interventions rather than direct evidence. Five intervention families were identified, spanning barrier-reduction, co-produced navigation, trauma-responsive, community-connected, and skills-training approaches. Of 15 prioritized programme theories, five demonstrated strong-to-moderate evidence, with the majority of actionable insights concentrated in appointment and onward referral stages. Discussion: Social prescribing appropriateness and effectiveness depends on alignment between contextual barriers, activated mechanisms, and support infrastructure. Three key cross-cutting concepts were identified: co-production as bidirectional exchange; safety as spatial and relational; and enabler provision as a barrier-matching requirement. Evidence limitations restrict wider generalizability, particularly regarding population reporting, further marginalized subgroups, and context considerations. Conclusion: Social prescribing for refugee support requires distinct consideration through adapted design, targeted barrier reduction, workforce investment, and genuine co-production with refugee-serving communities, rather than transferring dominant-population models. Evidence is strongest for in-appointment and onward referral strategies; access pathways into social prescribing remain the most critical evidence gap.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.